Patent reissue allows inventors to hedge their bets

The National Law Journal
October 2011

This article discusses how the Federal Circuit and D.C. Circuit decisions, In re Tanaka and Teva Pharmaceuticals USA Inc. v. Sebelius, have removed obstacles previously faced by branded pharmaceutical companies wishing to add narrow claims by reissue to their Orange Book listed patents.

View Attachment (PDF)